Patent · US Active

Treatment of Duchenne muscular dystrophy with myoblasts expressing dystrophin and treated to block myostatin signaling

US7887793B2 · kind B2 · utility

11Cited by

4References

17Claims

0Family size

Assignee

Université Laval · CA

Inventors

Jacques P. Tremblay · Laurelbrook Court, CA
Basma Fatouma Benabdallah · Magnolia Trace, CA

Key dates

Filing date	Mar 23, 2006
Grant date	Feb 15, 2011
Priority date	—
Expiry date	Mar 13, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/15043
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to methods and materials for enhancing muscle mass or for the treatment of muscle disease in a subject, comprising introducing a cell which has a lower than normal level of myostatin signalling, into the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.